The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Oragenics, Inc. - Biopharmaceutical Company Focused on Developing Antibiotics for Infectious Disease and Oral Mucositis

SNNLive spoke with Alan Joslyn, Ph.D., CEO of Oragenics, Inc. (NYSE American: OGEN) at "Media Day" 2018 hosted by Continental Stock Transfer & Trust Company in New York City, NY.

Share With

Thursday, October 04, 2018

   

© 2018 Stock News Now